Author:
Godlewska B R,Olajossy-Hilkesberger L,Ciwoniuk M,Olajossy M,Marmurowska-Michałowska H,Limon J,Landowski J
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference31 articles.
1. Fontaine KR, Heo M, Harrigan EP, Shear CL, Lakshminarayanan M, Casey DE et al. Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate. Psychiatry Res 2001; 101: 277–288.
2. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686–1696.
3. Wirshing DA, Wirshing WC, Kysar L, Berisford MA, Goldstein D, Pashdag J et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 1999; 60: 358–363.
4. Vickers SP, Easton N, Webster LJ, Wyatt A, Bickerdike MJ, Dourish CT et al. Oral administration of the HTR2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology (Berl) 2003; 167: 274–280.
5. Sargent PA, Sharpley AL, Williams C, Goodall EM, Cowen PJ . HTR2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology (Berl) 1997; 133: 309–312.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献